How do you manage stakeholder expectations and feedback on GDP change proposals?
GDP change proposals are inevitable in the pharmaceutical industry, as new regulations, technologies, and customer demands require continuous improvement and adaptation of the distribution processes. However, implementing these changes can be challenging, especially when they involve multiple stakeholders with different expectations and feedback. How do you manage these aspects effectively and ensure compliance, quality, and efficiency? Here are some tips to help you with your GDP change control procedure.